About this trial
The aim of this prospective cohort study is to compare the esthetic, clinical and patient-centered outcomes following immediate and delayed implant placement protocols.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
At least 18 years old and able to understand an informed consent
Adequate oral hygiene to allow for implant therapy consistent with standards of care.
Missing a single tooth in the maxillary anterior region
Presence of adjacent natural teeth
Disqualifiers
Poor oral hygiene
Severe parafunctional habits, for example, bruxing and clenching
Presence of clinically active periodontal disease as expressed by probing pocket depths≥4 mm in combination with bleeding on probing.
Conditions that might lead to a possibly lowered regenerative capacity of the bone, for example, osteoporosis and Paget's disease
Trial design
Parallel
Treatments tested in this trial
Type 1 implant placement
Procedure/SurgeryImplant is placed immediately following tooth extraction in one surgical procedure
Type 3 implant placement
Procedure/SurgeryImplant is placed in the site which is left to heal for 3 months following tooth extraction
Treatment groups
Trial outcomes
Primary outcomes
Pink and white esthetic scores (PES/WES)
Baseline will be at the time of implant placement.Pink and white esthetic scores (PES/WES) will be recorded at 0.5, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Radiographic bone volume
Radiographic bone volume be assessed at pre-operation, 0 ,1.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Secondary outcomes
Implant survival
Implant survival will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Probing depth
Probing depth will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Modified plaque index
Modified plaque index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Modified bleeding index
Modified bleeding index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.